Symbol
| SLC25A5
| contributors: mct - updated : 22-05-2016
|
HGNC name
| solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5
|
HGNC id
| 10991
|
corresponding disease(s)
|
HARTS
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
| deletion
|  
|  
|
in patients with non-syndromic ntellectual disability (ID) plus some additional features | constitutional
|  
|  
| --low
|  
|
caused anemia in a cell-autonomous manner by maturation arrest of erythroid precursors with increased reactive oxygen species and premature deaths | constitutional
|  
|  
| --over
|  
|
overexpression of SLC25A5 promoted cell growth and glycolysis | |
Variant & Polymorphism
|
| |
Candidate gene
| candidate for cancer therapy based on molecular targeting |
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | lung | | |
and that SLC25A5 targeting may be considered a novel strategy for overcoming EGFR-TKI resistance in Non-Small Cell Lung Cancer (PMID: 26883272) |
| | |